Diagnostic Microbiology and Infectious Disease

Papers
(The H4-Index of Diagnostic Microbiology and Infectious Disease is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-12-01 to 2024-12-01.)
ArticleCitations
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)81
The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review78
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection60
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals54
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center46
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples45
COVID-19 in Brazil: 150,000 deaths and the Brazilian underreporting41
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection38
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type36
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities34
The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.34
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-1932
Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review32
Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study31
Activity of aztreonam in combination with ceftazidime–avibactam against serine- and metallo-β-lactamase–producing Pseudomonas aeruginosa30
Advances in rapid diagnostics for bloodstream infections28
Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples28
Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectio28
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies28
Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel28
Detection of SARS-CoV-2 IgG antibodies in dried blood spots27
Changes in healthcare managing COVID and non–COVID-19 patients during the pandemic: striking the balance27
In vitro activity of Ceftazidime–Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 201926
Time to positivity of acute and chronic periprosthetic joint infection cultures25
A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia25
0.10527205467224